Study Oversight
The original protocol and all amendments were approved by the Swedish Medical Product Agency (EudraCT No. 2013-000564-29) and the Regional Ethical Review Board at the University of Gothenburg (Dnr 144-13). The study was registered at ClinicalTrials.gov (identifier: 